Evidence map›Paper›PMID 36187404›Full record

ArticleWorld journal of gastrointestinal oncology2022

Clinical implications of interleukins-31, 32, and 33 in gastric cancer.

Qing-Hua Liu, Ji-Wei Zhang, Lei Xia, Steven G Wise, Brett David Hambly, Kun Tao, Shi-San Bao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qing-Hua LiuDepartment of Pathology, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China.
Ji-Wei ZhangDepartment of Surgery, The Central Hospital of Songjiang District, Shanghai Jiaotong University, Shanghai 201699, Shanghai, China.
Lei XiaDepartment of Pathology, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China.
Steven G WiseFaculty of Medicine and Health, School of Medical Sciences, University of Sydney, Sydney 2006, NSW, Australia.
Brett David HamblyDepartment of Pathology,Tongren Hospital, Shanghai 200336, China.
Kun TaoDepartment of Pathology,Tongren Hospital, Shanghai 200336, China.
Shi-San BaoDepartment of Pathology,Tongren Hospital, Shanghai 200336, China. profbao@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer (GC) is one of the most common malignancies in China with a high morbidity and mortality.

aimTo determine whether interleukin (IL)-31, IL-32, and IL-33 can be used as biomarkers for the detection of GC,

methodsTissue array (

resultsWe found that the expression levels of IL-31, IL-32, and IL-33 were all lower in GC than in adjacent non-GC gastric tissues (

conclusionOur findings may provide new insights into the roles of IL-31, IL-32, and IL-33 in the carcinogenesis of GC and demonstrate their relative usefulness as prognostic markers for GC. The underlying mechanism of IL-31, IL-32, and IL-33 actions in GC should be further explored.

Indexed as

Diagnosis and therapyGastric cancerImmune cell interactionsInterleukin-31Interleukin32Interleukin-33

Identifiers

PMID36187404
PMCPMC9516641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.